BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma

[1]  Sang Kook Lee,et al.  The Dual Role of Bone Morphogenetic Proteins in Cancer , 2017, Molecular therapy oncolytics.

[2]  Shu-Ching Hsieh,et al.  Alpha-Mangostin Suppresses the Metastasis of Human Renal Carcinoma Cells by Targeting MEK/ERK Expression and MMP-9 Transcription Activity , 2017, Cellular Physiology and Biochemistry.

[3]  G. Basso,et al.  A synthetic BMP-2 mimicking peptide induces glioblastoma stem cell differentiation. , 2017, Biochimica et biophysica acta. General subjects.

[4]  H. Frieboes,et al.  3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy. , 2017, Cancer research.

[5]  J. Moffat,et al.  Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Galina A. Erikson,et al.  Stem Cell Reports Resource Differentiation of Inflammation-Responsive Astrocytes fromGlial Progenitors Generated from Human Induced Pluripotent Stem Cells , 2017 .

[7]  K. Miyake,et al.  Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response , 2017, Brain Tumor Pathology.

[8]  J. Behnan,et al.  Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency , 2016, Oncogene.

[9]  R. Mirimanoff,et al.  Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG , 2015, Neuro-oncology.

[10]  H. Duffau,et al.  Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells , 2016, Stem cells international.

[11]  K. Young,et al.  Neural Stem and Progenitor Cells in Nervous System Function and Therapy , 2016, Stem cells international.

[12]  G. Basso,et al.  Annexin 2A sustains glioblastoma cell dissemination and proliferation , 2016, Oncotarget.

[13]  Q. Shi,et al.  BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cell‑derived microenvironment through the MAPK/ERK and NF-κB pathways. , 2016, Oncology reports.

[14]  G. Basso,et al.  The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation , 2016, Scientific Reports.

[15]  Franz Oswald,et al.  The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways. , 2016, Biochimica et biophysica acta.

[16]  Xian-Jun Qu,et al.  Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation. , 2016, Oncology reports.

[17]  S. Nelson,et al.  Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide , 2015, Molecular Cancer.

[18]  Ying-ying Chen,et al.  Biological roles of human bone morphogenetic protein 9 in the bone microenvironment of human breast cancer MDA-MB-231 cells. , 2015, American journal of translational research.

[19]  M. Goumans,et al.  Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors , 2015, Clinical Cancer Research.

[20]  G. Semenza,et al.  Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs. , 2015, Cardiovascular research.

[21]  A. Moustakas,et al.  Transforming growth factor β and bone morphogenetic protein actions in brain tumors , 2015, FEBS letters.

[22]  R. Wu,et al.  Inactivation of the Phosphatidylinositol 3‐Kinase/Akt Pathway is Involved in BMP9‐mediated Tumor‐suppressive Effects in Gastric Cancer Cells , 2015, Journal of cellular biochemistry.

[23]  Jing Liu,et al.  Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets , 2015, Biomarker Research.

[24]  Tongchuan He,et al.  BMP9 Inhibits Proliferation and Metastasis of HER2-Positive SK-BR-3 Breast Cancer Cells through ERK1/2 and PI3K/AKT Pathways , 2014, PloS one.

[25]  M. Garcia‐Fuentes,et al.  Implantable controlled release devices for BMP-7 delivery and suppression of glioblastoma initiating cells. , 2014, Biomaterials.

[26]  K. Hoang-Xuan,et al.  Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[27]  T. He,et al.  BMP9 signaling in stem cell differentiation and osteogenesis. , 2018, American journal of stem cells.

[28]  Q. Shi,et al.  BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression , 2014, Molecular Biology Reports.

[29]  G. O’Keeffe,et al.  BMP-Smad 1/5/8 signalling in the development of the nervous system , 2013, Progress in Neurobiology.

[30]  Brendan D. O'Fallon,et al.  BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. , 2013, American journal of human genetics.

[31]  J. Li,et al.  Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion , 2013, Molecules and cells.

[32]  G. Basso,et al.  Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting. , 2013, Biochemical pharmacology.

[33]  D. Zagzag,et al.  Mechanisms of glioma-associated neovascularization. , 2012, The American journal of pathology.

[34]  R. Scienza,et al.  BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression , 2012, Cell Death and Disease.

[35]  L. Ricci-Vitiani,et al.  A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells , 2012, Cell Death and Differentiation.

[36]  M. Goumans,et al.  Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting* , 2012, The Journal of Biological Chemistry.

[37]  C. Beier,et al.  Chemoresistance of glioblastoma cancer stem cells - much more complex than expected , 2011, Molecular Cancer.

[38]  T. He,et al.  BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231 , 2011, Journal of Cancer Research and Clinical Oncology.

[39]  S. Pastorino,et al.  Transdifferentiation of glioblastoma cells into vascular endothelial cells , 2011, Proceedings of the National Academy of Sciences.

[40]  Mauro Biffoni,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[41]  Rong Wang,et al.  Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.

[42]  Q. Lan,et al.  Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro , 2010, Brain Research Bulletin.

[43]  Y. Marie,et al.  A New Alternative Mechanism in Glioblastoma Vascularization: Tubular Vasculogenic Mimicry , 2022 .

[44]  Chia-Ying Lin,et al.  Bone Morphogenetic Proteins and Cancer: Review of the Literature , 2010, Neurosurgery.

[45]  M. Goumans,et al.  Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis , 2010, The Journal of experimental medicine.

[46]  D. Wojchowski,et al.  BMP4 regulates vascular progenitor development in human embryonic stem cells through a smad‐dependent pathway , 2009, Journal of cellular biochemistry.

[47]  M. Campone,et al.  Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy , 2009 .

[48]  K. Boström,et al.  Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. , 2009, Blood.

[49]  Q. Wang,et al.  Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP‐9 , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[50]  L. Denaro,et al.  Hypoxia and HIF1α Repress the Differentiative Effects of BMPs in High‐Grade Glioma , 2009, Stem cells.

[51]  M. Rincón,et al.  Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival , 2008, International journal of biological sciences.

[52]  M. Alaoui-Ismaili,et al.  BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells* , 2008, Journal of Biological Chemistry.

[53]  Srdjan D. Antic,et al.  Radial Glia Cells in the Developing Human Brain , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[54]  I. Nakano,et al.  BMPing off glioma stem cells. , 2008, Cancer cell.

[55]  M. V. Dinther,et al.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.

[56]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[57]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[58]  G. Broggi,et al.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.

[59]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[60]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  G. Fuller,et al.  Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. , 2000, Cancer research.

[62]  D. Chaplin,et al.  Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis. , 1998, Seminars in radiation oncology.